Bispride MV 2mg/500mg/0.2mg Tablet SR
Marketer
Zenni Pharmaceutical Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Bispride MV 2mg/500mg/0.2mg Tablet SR
TriComb DM 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by helping regulate blood glucose. TriComb DM should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle factors significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Bispride MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Bispride MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Administer Bispride MV 2mg/500mg/0.2mg Tablet SR on an empty stomach.
Common Side effects of Bispride MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Bispride MV 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Bispride MV 2mg/500mg/0.2mg Sustained-Release tablets should be taken on an empty stomach.
How Bispride MV 2mg/500mg/0.2mg Tablet SR works:
Bispride MV extended-release tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bispride MV 2mg/500mg/0.2mg Tablet SR with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Bispride MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Bispride MV tablet (2mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Bispride MV 2mg/500mg/0.2mg SR tablets pose a likely risk for individuals with kidney impairment and should be omitted. Medical advice is essential. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Bispride MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, initiation with a low dose is typical; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Bispride MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Bispride MV 2mg/500mg/0.2mg SR Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Bispride MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently